+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Molecular Quality Controls Market Size, Share & Industry Trends Analysis Report By Analyte Type, By Application, By Product, By End User, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 320 Pages
  • April 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5600727
The Global Molecular Quality Controls Market size is expected to reach $259.4 million by 2028, rising at a market growth of 6.6% CAGR during the forecast period.

Molecular quality controls are used to assess the performance of molecular tests like leukocyte reduced apheresis platelet (LRAP) units, virus load assays, pathogen detection, and healthcare-associated infections (HAIs) such as pneumonia and urinary tract infections, among others. For research and clinical laboratories, blood diagnostic centers, and IVD makers, these products are primarily focused on quality control, defect detection, and validation panels to aid in the installation and monitoring of assay-kit lot performance.

According to the World Health Organization, early detection and treatment of cancer can avert 30-50 percent of cancer-related deaths. In this case, personalized medicine appears to be the most effective alternative for addressing diseases that aren"t well-known for responding well to current therapies or cures. According to research provided by the PMC (Personalized Medicine Coalition), personalized medicines accounted for only 5% of novel FDA-approved molecular entities in 2005, but more than 25% in 2016. Furthermore, 42% of all compounds in the pipeline and 73% of oncology compounds have the potential to be individualized therapies. Biopharmaceutical companies" R&D investments in personalized pharmaceuticals have nearly doubled in the last five years, according to the PMC, and are predicted to expand by 33% in the next few years. Biopharmaceutical researchers estimate a 69% increase in the number of individualized medications in development over the next five years, according to the same survey.



COVID-19 Impact Analysis

The COVID-19 outbreak had a negative impact on various business domains. Lockdowns stemming from the COVID-19 pandemic compelled to postpone medical appointments, reducing the number of tests performed and reagent sales. However, as governments increasingly loosen travel restrictions, there is a rebound in testing numbers. With the COVID-19 pandemic, dealing with contagious diseases has become a major medical concern around the world. Aside from vaccinations and therapeutic medications, there is an increasing demand for more accurate and simple testing technologies, as well as the proliferation of testing structures. This is bound to result in an increase in the demand for molecular quality control in the near future. As governments of various countries and health professionals face unprecedented problems, COVID-19 has had an impact on the regulatory environment and practices.

Market Growth Factors


The Rising Number of Accredited Clinical Laboratories

Clinical laboratories have proven to be one of the most important components of the modern healthcare value chain. Clinical laboratory tests have aided not only in the diagnosis of disease but also in the monitoring of therapy efficacy, and thus their demand has grown among the people. Clinical laboratories all around the world are attempting to gain accreditation on a national and international level in order to provide more dependable and better laboratory services. Molecular diagnostic laboratories undertake more complicated tests, are subject to stricter regulatory criteria, and are subject to a higher level of regulatory control.

High demand for Independent Controls and Multi-Analyte Control

Since they are manufactured independently of the instrument, reagents, and calibrators, independent controls are expected to have the largest Market share in the molecular quality controls Market due to their highly accurate, impartial, and independent assessment of a testing system or method performance test results in a short time with the highest sensitivity rate. Furthermore, a sharp increase in the usage of these products among third-party independent quality controls is likely to boost the Market, owing to advantages such as a wide range of applications and lower operational costs.

Market Restraining Factors


Evolving Regulatory Framework

Regulatory and regulatory standards for in vitro diagnostics (including molecular diagnostics), generally known as IVD, are growing more stringent in the United States and Europe. In the United States and Europe, regulatory and legal criteria for including molecular diagnostics are getting more stringent as well. As a result, any changes to the device will necessitate the creation of new guidance manuals. IVD products are defined and regulated in the United States under 21 CFR 809, the same rules that apply to medical devices. New FDA guidance materials have been released by the FDA. Device manufacturers must file a 510(k) application to the US Food and Drug Administration for any future modifications to a device.


Analyte Type Outlook

Based on Analyte Type, the Market is segmented into Single-analyte Controls and Multi-analyte Controls. The multi-analyte segment witnessed a significant revenue share in the molecular quality controls Market in 2021. As a result of technological advancements, new multi-analyte and multi-instrument controllers have been developed. Clinical laboratories can save money by combining many instrument-specific controls into a single control. Furthermore, by removing the need for separate QC processes for each analyte, these controls save time. Due to the widespread availability of such molecular quality controls for infectious disease diagnostics and other uses, the Market growth is likely to accelerate in the near future.

Application Outlook

Based on Application, the Market is segmented into Infectious Diseases Diagnostics, Oncology Testing, Genetic Testing, and Others. The infection diseases diagnostics segment acquired the largest revenue share in the molecular quality controls Market in 2021. The advent of sophisticated assays for infectious diseases, a significant increase in the prevalence of infectious diseases, and increased awareness in the medical community about the efficient use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases are all factors contributing to this segment's size.

Product Outlook

Based on Product, the Market is segmented into Independent Controls and Instrument-specific Controls (PCR, DNA Sequencing & NGS, and Others). The instrument-specific controls segment witnessed a substantial revenue share in the molecular quality controls Market in 2021. Clinical laboratories are able to save money by combining multiple instrument-specific controls into a single control. Furthermore, by removing the need for separate QC procedures for each analyte, these controls save time.

End User Outlook

Based on End User, the Market is segmented into Diagnostic Laboratories, Hospitals, IVD Manufacturers & CROs, Academic & Research Institutes, and Others. The diagnostic laboratories segment acquired the largest revenue share in the molecular quality controls Market in 2021. The number of accredited diagnostic laboratories is expected to increase in the coming years, providing potential prospects. Due to the increased need for molecular quality control, growing adoption of QC techniques, rising occurrences of regulatory actions, and rising expenditure on molecular diagnostics, the diagnostic laboratories segment is an important segment in the Market. Clinical Laboratory Improvement Amendments (CLIA) were introduced by the Centers for Medicare & Medicaid Services, and they have been instrumental in increasing the rate of adoption of Molecular Quality Control procedures in clinical laboratories.

Regional Outlook

Based on Regions, the Market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America acquired the largest revenue share in the molecular quality controls Market in 2021. It is due to the substantially developed healthcare systems in the United States and Canada, the existence of many leading molecular quality control product manufacturers in the region, and easy access to technologically advanced products.

The Market research report covers the analysis of key stake holders of the Market. Key companies profiled in the report include Grifols, S.A, Abbott Laboratories, Quidel Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Seegene, Inc., Randox Laboratories Limited, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, and Microbiologics, Inc.

Recent Strategies Deployed in Molecular Quality Controls Market

  • Jul-2021: Bio-Rad Laboratories entered into a partnership with Seegene, a key player in the multiplex molecular diagnostics Market. The partnership aimed at the development and commercialization of infectious disease molecular diagnostic products. In addition, Seegene is expected to offer diagnostic tests for use on Bio-Rad's CFX96 Dx Real-Time PCR System for U.S. Market s pending clinical development and clearance from The U.S. Food & amp; Drug Administration (FDA).
  • Jul-2020: Roche Diagnostics unveiled the cobas prime Pre-analytical System, a system that minimize repetitive manual tasks related to processing the large number and wide range of sample tubes, vials, and containers observed in modern molecular labs. This system offers efficient automation for regular, high-quality pre-analytics, which eventually results in greater confidence in results from downstream instruments.
  • Mar-2020: Thermo Fisher Scientific introduced Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control, an updated quality control product to monitor and validate COVID-19 molecular diagnostics tests. This control was designed as a synthetic RNA, non-infectious control.
  • Mar-2020: Microbiologics released a SARS-CoV-2 IVD control, a novel IVD product within its Helix EliteTM line of molecular controls. The product is designed to deliver quality control measures for the development, verification, and validation of diagnostic tests while having the accuracy and ease of use of the Helix EliteTM line. It is created for extended use and flexibility to catch up to the lightning speed of high-volume testing.
  • Oct-2018: Grifols received FDA approval for its ID CORE XT molecular diagnostic test. The approval was given to it for its use in in-vitro diagnostic (IVD) usage in the United States. Patients who need continual transfusions including individuals with hemoglobinopathies like thalassemia and sickle-cell disease will be benefited from the ID CORE XT kit.

Scope of the Study


Market Segments Covered in the Report:


By Analyte Type
  • Single-analyte Controls
  • Multi-analyte Controls
By Application
  • Infectious Diseases Diagnostics
  • Oncology Testing
  • Genetic Testing
  • Others
By Product
  • Independent Controls
  • Instrument-specific Controls
    • PCR
    • DNA Sequencing & amp; NGS
    • Others
By End User
  • Diagnostic Laboratories
  • Hospitals
  • IVD Manufacturers & amp; CROs
  • Academic & amp; Research Institutes
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Grifols, S.A
  • Abbott Laboratories
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Seegene, Inc.
  • Randox Laboratories Limited
  • F. Hoffmann-La Roche Ltd.
  • Bio-Techne Corporation
  • Microbiologics, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Molecular Quality Controls Market, by Analyte Type
1.4.2 Global Molecular Quality Controls Market, by Application
1.4.3 Global Molecular Quality Controls Market, by Product
1.4.4 Global Molecular Quality Controls Market, by End User
1.4.5 Global Molecular Quality Controls Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Molecular Quality Controls Market
Chapter 4. Global Molecular Quality Controls Market by Analyte Type
4.1 Global Single-analyte Controls Market by Region
4.2 Global Multi-analyte Controls Market by Region
Chapter 5. Global Molecular Quality Controls Market by Application
5.1 Global Infectious Diseases Diagnostics Market by Region
5.2 Global Oncology Testing Market by Region
5.3 Global Genetic Testing Market by Region
5.4 Global Other Application Market by Region
Chapter 6. Global Molecular Quality Controls Market by Product
6.1 Global Independent Controls Market by Region
6.2 Global Instrument-specific Controls Market by Region
6.3 Global Molecular Quality Controls Market by Instrument-specific Controls Type
6.3.1 Global PCR Market by Region
6.3.2 Global DNA Sequencing & NGS Market by Region
6.3.3 Global Others Market by Region
Chapter 7. Global Molecular Quality Controls Market by End User
7.1 Global Diagnostic Laboratories Market by Region
7.2 Global Hospitals Market by Region
7.3 Global IVD Manufacturers & CROs Market by Region
7.4 Global Academic & Research Institutes Market by Region
7.5 Global Others Market by Region
Chapter 8. Global Molecular Quality Controls Market by Region
8.1 North America Molecular Quality Controls Market
8.1.1 North America Molecular Quality Controls Market by Analyte Type
8.1.1.1 North America Single-analyte Controls Market by Country
8.1.1.2 North America Multi-analyte Controls Market by Country
8.1.2 North America Molecular Quality Controls Market by Application
8.1.2.1 North America Infectious Diseases Diagnostics Market by Country
8.1.2.2 North America Oncology Testing Market by Country
8.1.2.3 North America Genetic Testing Market by Country
8.1.2.4 North America Other Application Market by Country
8.1.3 North America Molecular Quality Controls Market by Product
8.1.3.1 North America Independent Controls Market by Country
8.1.3.2 North America Instrument-specific Controls Market by Country
8.1.3.3 North America Molecular Quality Controls Market by Instrument-specific Controls Type
8.1.3.3.1 North America PCR Market by Country
8.1.3.3.2 North America DNA Sequencing & NGS Market by Country
8.1.3.3.3 North America Others Market by Country
8.1.4 North America Molecular Quality Controls Market by End User
8.1.4.1 North America Diagnostic Laboratories Market by Country
8.1.4.2 North America Hospitals Market by Country
8.1.4.3 North America IVD Manufacturers & CROs Market by Country
8.1.4.4 North America Academic & Research Institutes Market by Country
8.1.4.5 North America Others Market by Country
8.1.5 North America Molecular Quality Controls Market by Country
8.1.5.1 US Molecular Quality Controls Market
8.1.5.1.1 US Molecular Quality Controls Market by Analyte Type
8.1.5.1.2 US Molecular Quality Controls Market by Application
8.1.5.1.3 US Molecular Quality Controls Market by Product
8.1.5.1.4 US Molecular Quality Controls Market by End User
8.1.5.2 Canada Molecular Quality Controls Market
8.1.5.2.1 Canada Molecular Quality Controls Market by Analyte Type
8.1.5.2.2 Canada Molecular Quality Controls Market by Application
8.1.5.2.3 Canada Molecular Quality Controls Market by Product
8.1.5.2.4 Canada Molecular Quality Controls Market by End User
8.1.5.3 Mexico Molecular Quality Controls Market
8.1.5.3.1 Mexico Molecular Quality Controls Market by Analyte Type
8.1.5.3.2 Mexico Molecular Quality Controls Market by Application
8.1.5.3.3 Mexico Molecular Quality Controls Market by Product
8.1.5.3.4 Mexico Molecular Quality Controls Market by End User
8.1.5.4 Rest of North America Molecular Quality Controls Market
8.1.5.4.1 Rest of North America Molecular Quality Controls Market by Analyte Type
8.1.5.4.2 Rest of North America Molecular Quality Controls Market by Application
8.1.5.4.3 Rest of North America Molecular Quality Controls Market by Product
8.1.5.4.4 Rest of North America Molecular Quality Controls Market by End User
8.2 Europe Molecular Quality Controls Market
8.2.1 Europe Molecular Quality Controls Market by Analyte Type
8.2.1.1 Europe Single-analyte Controls Market by Country
8.2.1.2 Europe Multi-analyte Controls Market by Country
8.2.2 Europe Molecular Quality Controls Market by Application
8.2.2.1 Europe Infectious Diseases Diagnostics Market by Country
8.2.2.2 Europe Oncology Testing Market by Country
8.2.2.3 Europe Genetic Testing Market by Country
8.2.2.4 Europe Other Application Market by Country
8.2.3 Europe Molecular Quality Controls Market by Product
8.2.3.1 Europe Independent Controls Market by Country
8.2.3.2 Europe Instrument-specific Controls Market by Country
8.2.3.3 Europe Molecular Quality Controls Market by Instrument-specific Controls Type
8.2.3.3.1 Europe PCR Market by Country
8.2.3.3.2 Europe DNA Sequencing & NGS Market by Country
8.2.3.3.3 Europe Others Market by Country
8.2.4 Europe Molecular Quality Controls Market by End User
8.2.4.1 Europe Diagnostic Laboratories Market by Country
8.2.4.2 Europe Hospitals Market by Country
8.2.4.3 Europe IVD Manufacturers & CROs Market by Country
8.2.4.4 Europe Academic & Research Institutes Market by Country
8.2.4.5 Europe Others Market by Country
8.2.5 Europe Molecular Quality Controls Market by Country
8.2.5.1 Germany Molecular Quality Controls Market
8.2.5.1.1 Germany Molecular Quality Controls Market by Analyte Type
8.2.5.1.2 Germany Molecular Quality Controls Market by Application
8.2.5.1.3 Germany Molecular Quality Controls Market by Product
8.2.5.1.4 Germany Molecular Quality Controls Market by End User
8.2.5.2 UK Molecular Quality Controls Market
8.2.5.2.1 UK Molecular Quality Controls Market by Analyte Type
8.2.5.2.2 UK Molecular Quality Controls Market by Application
8.2.5.2.3 UK Molecular Quality Controls Market by Product
8.2.5.2.4 UK Molecular Quality Controls Market by End User
8.2.5.3 France Molecular Quality Controls Market
8.2.5.3.1 France Molecular Quality Controls Market by Analyte Type
8.2.5.3.2 France Molecular Quality Controls Market by Application
8.2.5.3.3 France Molecular Quality Controls Market by Product
8.2.5.3.4 France Molecular Quality Controls Market by End User
8.2.5.4 Russia Molecular Quality Controls Market
8.2.5.4.1 Russia Molecular Quality Controls Market by Analyte Type
8.2.5.4.2 Russia Molecular Quality Controls Market by Application
8.2.5.4.3 Russia Molecular Quality Controls Market by Product
8.2.5.4.4 Russia Molecular Quality Controls Market by End User
8.2.5.5 Spain Molecular Quality Controls Market
8.2.5.5.1 Spain Molecular Quality Controls Market by Analyte Type
8.2.5.5.2 Spain Molecular Quality Controls Market by Application
8.2.5.5.3 Spain Molecular Quality Controls Market by Product
8.2.5.5.4 Spain Molecular Quality Controls Market by End User
8.2.5.6 Italy Molecular Quality Controls Market
8.2.5.6.1 Italy Molecular Quality Controls Market by Analyte Type
8.2.5.6.2 Italy Molecular Quality Controls Market by Application
8.2.5.6.3 Italy Molecular Quality Controls Market by Product
8.2.5.6.4 Italy Molecular Quality Controls Market by End User
8.2.5.7 Rest of Europe Molecular Quality Controls Market
8.2.5.7.1 Rest of Europe Molecular Quality Controls Market by Analyte Type
8.2.5.7.2 Rest of Europe Molecular Quality Controls Market by Application
8.2.5.7.3 Rest of Europe Molecular Quality Controls Market by Product
8.2.5.7.4 Rest of Europe Molecular Quality Controls Market by End User
8.3 Asia Pacific Molecular Quality Controls Market
8.3.1 Asia Pacific Molecular Quality Controls Market by Analyte Type
8.3.1.1 Asia Pacific Single-analyte Controls Market by Country
8.3.1.2 Asia Pacific Multi-analyte Controls Market by Country
8.3.2 Asia Pacific Molecular Quality Controls Market by Application
8.3.2.1 Asia Pacific Infectious Diseases Diagnostics Market by Country
8.3.2.2 Asia Pacific Oncology Testing Market by Country
8.3.2.3 Asia Pacific Genetic Testing Market by Country
8.3.2.4 Asia Pacific Other Application Market by Country
8.3.3 Asia Pacific Molecular Quality Controls Market by Product
8.3.3.1 Asia Pacific Independent Controls Market by Country
8.3.3.2 Asia Pacific Instrument-specific Controls Market by Country
8.3.3.3 Asia Pacific Molecular Quality Controls Market by Instrument-specific Controls Type
8.3.3.3.1 Asia Pacific PCR Market by Country
8.3.3.3.2 Asia Pacific DNA Sequencing & NGS Market by Country
8.3.3.3.3 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Molecular Quality Controls Market by End User
8.3.4.1 Asia Pacific Diagnostic Laboratories Market by Country
8.3.4.2 Asia Pacific Hospitals Market by Country
8.3.4.3 Asia Pacific IVD Manufacturers & CROs Market by Country
8.3.4.4 Asia Pacific Academic & Research Institutes Market by Country
8.3.4.5 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Molecular Quality Controls Market by Country
8.3.5.1 China Molecular Quality Controls Market
8.3.5.1.1 China Molecular Quality Controls Market by Analyte Type
8.3.5.1.2 China Molecular Quality Controls Market by Application
8.3.5.1.3 China Molecular Quality Controls Market by Product
8.3.5.1.4 China Molecular Quality Controls Market by End User
8.3.5.2 Japan Molecular Quality Controls Market
8.3.5.2.1 Japan Molecular Quality Controls Market by Analyte Type
8.3.5.2.2 Japan Molecular Quality Controls Market by Application
8.3.5.2.3 Japan Molecular Quality Controls Market by Product
8.3.5.2.4 Japan Molecular Quality Controls Market by End User
8.3.5.3 India Molecular Quality Controls Market
8.3.5.3.1 India Molecular Quality Controls Market by Analyte Type
8.3.5.3.2 India Molecular Quality Controls Market by Application
8.3.5.3.3 India Molecular Quality Controls Market by Product
8.3.5.3.4 India Molecular Quality Controls Market by End User
8.3.5.4 South Korea Molecular Quality Controls Market
8.3.5.4.1 South Korea Molecular Quality Controls Market by Analyte Type
8.3.5.4.2 South Korea Molecular Quality Controls Market by Application
8.3.5.4.3 South Korea Molecular Quality Controls Market by Product
8.3.5.4.4 South Korea Molecular Quality Controls Market by End User
8.3.5.5 Singapore Molecular Quality Controls Market
8.3.5.5.1 Singapore Molecular Quality Controls Market by Analyte Type
8.3.5.5.2 Singapore Molecular Quality Controls Market by Application
8.3.5.5.3 Singapore Molecular Quality Controls Market by Product
8.3.5.5.4 Singapore Molecular Quality Controls Market by End User
8.3.5.6 Malaysia Molecular Quality Controls Market
8.3.5.6.1 Malaysia Molecular Quality Controls Market by Analyte Type
8.3.5.6.2 Malaysia Molecular Quality Controls Market by Application
8.3.5.6.3 Malaysia Molecular Quality Controls Market by Product
8.3.5.6.4 Malaysia Molecular Quality Controls Market by End User
8.3.5.7 Rest of Asia Pacific Molecular Quality Controls Market
8.3.5.7.1 Rest of Asia Pacific Molecular Quality Controls Market by Analyte Type
8.3.5.7.2 Rest of Asia Pacific Molecular Quality Controls Market by Application
8.3.5.7.3 Rest of Asia Pacific Molecular Quality Controls Market by Product
8.3.5.7.4 Rest of Asia Pacific Molecular Quality Controls Market by End User
8.4 LAMEA Molecular Quality Controls Market
8.4.1 LAMEA Molecular Quality Controls Market by Analyte Type
8.4.1.1 LAMEA Single-analyte Controls Market by Country
8.4.1.2 LAMEA Multi-analyte Controls Market by Country
8.4.2 LAMEA Molecular Quality Controls Market by Application
8.4.2.1 LAMEA Infectious Diseases Diagnostics Market by Country
8.4.2.2 LAMEA Oncology Testing Market by Country
8.4.2.3 LAMEA Genetic Testing Market by Country
8.4.2.4 LAMEA Other Application Market by Country
8.4.3 LAMEA Molecular Quality Controls Market by Product
8.4.3.1 LAMEA Independent Controls Market by Country
8.4.3.2 LAMEA Instrument-specific Controls Market by Country
8.4.3.3 LAMEA Molecular Quality Controls Market by Instrument-specific Controls Type
8.4.3.3.1 LAMEA PCR Market by Country
8.4.3.3.2 LAMEA DNA Sequencing & NGS Market by Country
8.4.3.3.3 LAMEA Others Market by Country
8.4.4 LAMEA Molecular Quality Controls Market by End User
8.4.4.1 LAMEA Diagnostic Laboratories Market by Country
8.4.4.2 LAMEA Hospitals Market by Country
8.4.4.3 LAMEA IVD Manufacturers & CROs Market by Country
8.4.4.4 LAMEA Academic & Research Institutes Market by Country
8.4.4.5 LAMEA Others Market by Country
8.4.5 LAMEA Molecular Quality Controls Market by Country
8.4.5.1 Brazil Molecular Quality Controls Market
8.4.5.1.1 Brazil Molecular Quality Controls Market by Analyte Type
8.4.5.1.2 Brazil Molecular Quality Controls Market by Application
8.4.5.1.3 Brazil Molecular Quality Controls Market by Product
8.4.5.1.4 Brazil Molecular Quality Controls Market by End User
8.4.5.2 Argentina Molecular Quality Controls Market
8.4.5.2.1 Argentina Molecular Quality Controls Market by Analyte Type
8.4.5.2.2 Argentina Molecular Quality Controls Market by Application
8.4.5.2.3 Argentina Molecular Quality Controls Market by Product
8.4.5.2.4 Argentina Molecular Quality Controls Market by End User
8.4.5.3 UAE Molecular Quality Controls Market
8.4.5.3.1 UAE Molecular Quality Controls Market by Analyte Type
8.4.5.3.2 UAE Molecular Quality Controls Market by Application
8.4.5.3.3 UAE Molecular Quality Controls Market by Product
8.4.5.3.4 UAE Molecular Quality Controls Market by End User
8.4.5.4 Saudi Arabia Molecular Quality Controls Market
8.4.5.4.1 Saudi Arabia Molecular Quality Controls Market by Analyte Type
8.4.5.4.2 Saudi Arabia Molecular Quality Controls Market by Application
8.4.5.4.3 Saudi Arabia Molecular Quality Controls Market by Product
8.4.5.4.4 Saudi Arabia Molecular Quality Controls Market by End User
8.4.5.5 South Africa Molecular Quality Controls Market
8.4.5.5.1 South Africa Molecular Quality Controls Market by Analyte Type
8.4.5.5.2 South Africa Molecular Quality Controls Market by Application
8.4.5.5.3 South Africa Molecular Quality Controls Market by Product
8.4.5.5.4 South Africa Molecular Quality Controls Market by End User
8.4.5.6 Nigeria Molecular Quality Controls Market
8.4.5.6.1 Nigeria Molecular Quality Controls Market by Analyte Type
8.4.5.6.2 Nigeria Molecular Quality Controls Market by Application
8.4.5.6.3 Nigeria Molecular Quality Controls Market by Product
8.4.5.6.4 Nigeria Molecular Quality Controls Market by End User
8.4.5.7 Rest of LAMEA Molecular Quality Controls Market
8.4.5.7.1 Rest of LAMEA Molecular Quality Controls Market by Analyte Type
8.4.5.7.2 Rest of LAMEA Molecular Quality Controls Market by Application
8.4.5.7.3 Rest of LAMEA Molecular Quality Controls Market by Product
8.4.5.7.4 Rest of LAMEA Molecular Quality Controls Market by End User
Chapter 9. Company Profiles
9.1 Grifols, S.A
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Approvals:
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Quidel Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Seegene, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expense
9.7 Randox Laboratories Limited
9.7.1 Company Overview
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.9 Bio-Techne Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.10. Microbiologics, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:

Companies Mentioned

  • Grifols, S.A
  • Abbott Laboratories
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Seegene, Inc.
  • Randox Laboratories Limited
  • F. Hoffmann-La Roche Ltd.
  • Bio-Techne Corporation
  • Microbiologics, Inc.

Methodology

Loading
LOADING...